|
US6143718A
(en)
|
1995-06-07 |
2000-11-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of Type II diabetes mellutis with amylin agonists
|
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
AU2001293557A1
(en)
*
|
2000-09-19 |
2002-04-02 |
University Of Toronto |
New inhibitors of iapp fibril formation and uses thereof
|
|
NZ534557A
(en)
*
|
2002-01-08 |
2007-10-26 |
Amylin Pharmaceuticals Inc |
Use of amylin or amylin agonists in the manufacture of a medicament for use in the treatment of dyslipidemia, wherein the medicament reduces post-prandial triglyceride levels
|
|
US6923175B2
(en)
|
2002-03-20 |
2005-08-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
|
RU2385878C2
(ru)
*
|
2004-02-11 |
2010-04-10 |
Амилин Фармасьютикалз, Инк. |
Пептид, обладающий свойствами амилина (варианты), и его применение (варианты)
|
|
US7399744B2
(en)
*
|
2004-03-04 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition
|
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
|
KR20130066695A
(ko)
|
2004-08-23 |
2013-06-20 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
WO2006045603A1
(en)
*
|
2004-10-26 |
2006-05-04 |
Lonza Ag |
S-alkyl-sulphenyl protection groups in solid-phase synthesis
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
EP2455072A1
(en)
*
|
2005-03-11 |
2012-05-23 |
Endo Pharmaceuticals Solutions Inc. |
Controlled release formulations of octreotide
|
|
EP2258382A3
(en)
|
2005-03-31 |
2014-05-14 |
Amylin Pharmaceuticals, LLC |
Amylin and amylin agonists for treating psychiatric diseases and disorders
|
|
MX373000B
(es)
|
2005-09-14 |
2020-05-21 |
Mannkind Corp |
Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
|
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
|
US20090181890A1
(en)
*
|
2006-03-31 |
2009-07-16 |
Amylin Pharmaceuticals , Inc. |
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
|
|
EP2120985B1
(en)
|
2007-02-05 |
2012-06-27 |
Amylin Pharmaceuticals, Inc. |
FN-38 peptides for use in the treatment of psychotic and anxiety disorders
|
|
EP2211842B1
(en)
*
|
2007-10-24 |
2015-08-12 |
MannKind Corporation |
An inhalable dry powder formulation comprising glp-1 for use in the treatment of hyperglycemia and diabetes by pulmonary administration
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
CN101827626B
(zh)
|
2008-06-13 |
2015-03-18 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
|
ES2421385T3
(es)
|
2008-06-20 |
2013-09-02 |
Mannkind Corp |
Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
|
|
UA104866C2
(uk)
*
|
2008-06-25 |
2014-03-25 |
Ендо Фармас'Ютікалз Солюшнз Інк. |
Імплантат октреотиду, який містить вивільняючу речовину
|
|
WO2009158412A2
(en)
|
2008-06-25 |
2009-12-30 |
Endo Pharmaceuticals Solutions Inc. |
Sustained delivery of exenatide and other polypeptides
|
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
DK2405963T3
(da)
|
2009-03-11 |
2013-12-16 |
Mannkind Corp |
Apparat, system og fremgangsmåde til at måle modstand i en inhalator
|
|
RU2537181C2
(ru)
*
|
2009-03-12 |
2014-12-27 |
Нордик Байосайенс А/С |
Лечение диабета и метаболического синдрома
|
|
KR102584844B1
(ko)
|
2009-06-12 |
2023-10-04 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
CN102985125A
(zh)
|
2010-06-21 |
2013-03-20 |
曼金德公司 |
干粉药物输送系统和方法
|
|
SG194034A1
(en)
|
2011-04-01 |
2013-11-29 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
MX2014004983A
(es)
|
2011-10-24 |
2014-09-22 |
Mannkid Corp |
Metodos y composiciones para tratar dolor.
|
|
CA2868688A1
(en)
|
2012-04-03 |
2013-10-10 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
|
KR102264177B1
(ko)
|
2012-07-12 |
2021-06-11 |
맨카인드 코포레이션 |
건조 분말 약물 전달 시스템 및 방법
|
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
|
DK2968443T3
(da)
|
2013-03-15 |
2021-12-06 |
Protagonist Therapeutics Inc |
Hepcidinanaloger og anvendelser deraf
|
|
MX375448B
(es)
|
2013-07-18 |
2025-03-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
PT3143037T
(pt)
|
2014-05-16 |
2021-09-24 |
Protagonist Therapeutics Inc |
Antagonistas peptídicos tioéter de integrina alfa4beta7
|
|
US9624268B2
(en)
|
2014-07-17 |
2017-04-18 |
Protagonist Therapeutics, Inc. |
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
|
|
CN106687474A
(zh)
*
|
2014-09-04 |
2017-05-17 |
诺和诺德股份有限公司 |
新型胰淀素和降钙素受体激动剂
|
|
EP3201217A4
(en)
|
2014-10-01 |
2018-07-18 |
Protagonist Therapeutics Inc. |
Novel cyclic monomer and dimer peptides having integrin antagonist activity
|
|
KR20170108936A
(ko)
|
2014-10-01 |
2017-09-27 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
신규한 α4β7 펩타이드 단량체 및 이량체 길항제
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
KR101669140B1
(ko)
*
|
2015-04-28 |
2016-10-26 |
(주)케어젠 |
항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
US20190002503A1
(en)
|
2015-12-30 |
2019-01-03 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
EP3681900A4
(en)
|
2017-09-11 |
2021-09-08 |
Protagonist Therapeutics, Inc. |
OPIOID AGONIST PEPTIDES AND THEIR USES
|
|
EP3749345A4
(en)
|
2018-02-08 |
2022-04-06 |
Protagonist Therapeutics, Inc. |
CONJUGATED HEPCIDIN MIMETICS
|
|
TW202019948A
(zh)
|
2018-07-12 |
2020-06-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其治療發炎疾病之用途
|
|
CN114341161A
(zh)
|
2019-07-10 |
2022-04-12 |
领导医疗有限公司 |
白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
|
|
HRP20250769T1
(hr)
|
2020-01-15 |
2025-08-29 |
Janssen Biotech, Inc. |
Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti
|
|
AU2021209086A1
(en)
|
2020-01-15 |
2022-08-04 |
Janssen Biotech, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
AU2021383828A1
(en)
|
2020-11-20 |
2023-07-06 |
Janssen Pharmaceutica Nv |
Compositions of peptide inhibitors of interleukin-23 receptor
|
|
WO2023288019A2
(en)
|
2021-07-14 |
2023-01-19 |
Janssen Biotech, Inc. |
Lipidated peptide inhibitors of interleukin-23 receptor
|